|

GK01 Injection Clinical Trials

3 actively recruiting trials

Pipeline

Early 1: 1Phase 1: 2

Top Sponsors

  • Tianjin Medical University Cancer Institute and Hospital2
  • Beijing Geekgene Technology Co., LTD1

Indications

  • Cancer3
  • Advanced Solid Tumors2
  • Solid Tumors1

Other3 trials

A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
Early 1
A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor
Phase 1
A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.